Immediate dispatch available from GMP-aligned automated synthesis lines with verified HPLC & Mass Spectrometry batch certificates.
In-depth technical analysis for chemical engineers, B2B procurement specialists, and global compliance officers.
The global fine chemical and specialized steroid intermediate landscape has experienced a monumental paradigm shift over the past decade. The compound indexed under CAS 53-39-4 (Oxandrolone / 17β-hydroxy-17α-methyl-2-oxa-5α-androstan-3-one) occupies a pivotal technical niche due to its unique structural modification: the substitution of carbon-2 with an oxygen atom in the A-ring of the phenanthrene core. This heterocyclic modification drastically attenuates hepatic metabolism while preserving high targeted androgen receptor binding affinity.
Historically, commercial production suffered from low-yield, multistage semi-synthetic routes originating from stigmasterol or diosgenin. Modern industrial chemistry has transitioned toward continuous-flow microreactors and stereoselective catalytic lactonization. Advanced synthesis facilities employ modern green chemistry oxidants, eliminating toxic hexavalent chromium reagents, and ensuring that residual heavy metal impurities remain strictly below the stringent ICH Q3D threshold of <10 ppm.
Global procurement teams in pharmaceutical development and academic biochemistry require unprecedented traceability. Rather than assessing simple percentage purities, modern B2B buyers scrutinize chiral resolution, residual organic solvent residues (ICH Q3C Class 2/3 limits via Headspace GC), and polymorphic crystal consistency (Form I vs Form II) to guarantee predictable bioavailability in downstream formulations.
Analytical chromatographic resolution exceeds 99.0% by gradient RP-HPLC. Routine mass spectrometry (LC-MS-ESI) confirms the molecular weight of 306.44 g/mol without trace epimerization or synthesis intermediaries.
Every commercial batch is paired with verifiable Certificate of Analysis (COA), complete NMR spectral traces (1H, 13C), FTIR characterization, and validation against USP/EP pharmacopeial monographs.
Differential Scanning Calorimetry (DSC) and X-ray Powder Diffraction (XRPD) verify thermodynamic stability, ensuring uncompromised crystalline integrity across varying ambient humidity and transport environments.
Navigating global regulatory barriers, customs compliance, and supply continuity in API manufacturing.
Procuring CAS 53-39-4 on an industrial scale requires managing international legal structures, customs import regulations, and multi-tier quality assurance audits. In the European Union and North America, regulatory authorities impose stringent documentation standards for raw chemical precursors and intermediate compounds. Importers are legally obligated to prove that synthesis routes do not utilize prohibited precursors and that all products adhere to environmental REACH compliance mandates.
A persistent risk for international procurement executives is batch-to-batch variation from uncertified intermediaries. Smaller manufacturing outfits often rely on seasonal, manual crystallization protocols that introduce unacceptable disparities in particle size distribution (PSD). In contrast, tier-one global chemical purchasers require precise micronization (D90 < 20 μm) to maintain steady dissolution dynamics in formulation matrices.
| Analytical Parameter | Tier-1 Factory Benchmark (Modern) | Legacy / Secondary Producer Standard | Strategic Impact on Buyer |
|---|---|---|---|
| Assay by HPLC (Anhydrous) | 99.2% – 99.8% | 97.0% – 98.5% | Higher operational yields, zero off-target batch loss |
| Related Substances (Total Impurities) | ≤ 0.5% (Max single: ≤ 0.1%) | ≥ 1.5% (Unresolved isomer peaks) | Mitigates regulatory rejection by customs & QA |
| Residual Solvents (Headspace GC) | Meets ICH Q3C Class 2/3 limits | Variable, often exceeding solvent limits | Guarantees human research baseline safety |
| Heavy Metal Limits (ICP-MS) | ≤ 10 ppm (ICH Q3D Compliant) | Often unverified or >20 ppm | Essential for advanced academic & clinical trials |
| Supply Lead Time & Inventory | Direct ex-factory stock / 48-hr logistics dispatch | 4 to 8 weeks lag; broker dependent | Eliminates critical supply chain disruptions |
Transforming complex stereospecific synthesis through automated batch control, DCS infrastructure, and scalable logistics.
The modernization of Chinese fine chemical manufacturing has established Hebei and surrounding industrial corridors as central hubs for high-complexity small molecules and peptide synthesis. Through massive capital expenditure into Smart Factory 4.0 infrastructure, premier chemical factories have transitioned entirely to automated Distributed Control Systems (DCS), in-line process analytical technology (PAT), and continuous solvent recovery architectures.
For CAS 53-39-4 synthesis, automated DCS platforms continually monitor key reaction kinetics—including temperature gradients, stoichiometry dosing, and pH stability—during the critical stereoselective reduction steps. This continuous closed-loop control eliminates human operational error and ensures batch consistency across ton-scale output. Furthermore, China's end-to-end industrial ecosystem secures uninterrupted access to foundational basic reagents, eliminating the supply chain vulnerabilities that frequently paralyze Western chemical production.
Closed-loop, SCADA-integrated reactors deliver 100% computational monitoring over reaction kinetics, ensuring complete stereochemical fidelity and zero cross-contamination risk.
Real-time chromatographic monitoring allows for instantaneous reaction quenching at peak conversion yields, reducing byproduct synthesis to undetectable baseline levels.
Domestic integration of starting steroid cores guarantees 100% production uptime, insulating international buyers from geopolitical trade shocks and logistics delays.
Deploying CAS 53-39-4 across international laboratory, biomedical, and reference research environments.
Widely utilized by international doping control laboratories (WADA-accredited) and forensic analysis institutions as certified secondary and primary reference materials for GC-MS/MS and LC-HRMS quantification.
Academic institutions and biomedical research teams leverage high-purity compound profiles to investigate androgen receptor activation kinetics, transcriptional co-regulator recruitment, and androgenic vs. anabolic signaling divergence.
Used extensively in cellular in vitro models to explore protein synthesis acceleration pathways without concurrent aromatization to estrogenic metabolites, providing vital data for muscle-wasting research.
Direct technical and operational answers for cross-border purchasers, compliance teams, and laboratory managers.
Explore our fully audited, factory-direct research peptides, specialized hormone analogues, and organic raw materials.
